glycopyrrolate
NDC 71839-125, glycopyrrolate, injection, from BE Pharmaceuticals Inc..
- Product NDC
- 71839-125
- Status
- Listed
- Labeler
- BE Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211705
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71839-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE1 mg/5mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71839-125-25 | 71839012525 | 25 VIAL, MULTI-DOSE in 1 CARTON (71839-125-25) / 5 mL in 1 VIAL, MULTI-DOSE (71839-125-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d9df3900-a8c2-438b-8971-ba11ff91f90bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=71839-125
Use it
Look up 71839-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71839-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71839-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.